Clinical Trial Update: Oral Ifetroban in Subjects With Duchenne Muscular Dystrophy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for oral ifetroban in Duchenne muscular dystrophy patients, including those with cardiomyopathy, completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiomyopathy
• Dilated Cardiomyopathy
• Duchenne Muscular Dystrophy

Drugs mentioned

• Ifetroban (Ifetroban)

Snippet

Sponsor: Cumberland Pharmaceuticals | Conditions: Duchenne Muscular Dystrophy Cardiomyopathy, Cardiomyopathy, Dilated | Phase 2 | Status: COMPLETED | Results posted: 2026-01-26